Pharmafile Logo
Pharmafocus logo
Advanced Search

sepsis

Showing 4 posts of 4 posts found.

testalize-me-0je8ynv4mis-unsplash

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023
Research and Development FDA, Infections and infestations, Inflammatix, TriVerity, infection, sepsis

Inflammatix has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead …

News
tablets-1796506_960_720

Researchers in world-first study on antibiotic use for sepsis

June 28, 2017
Research and Development NHS, antibiotic, sepsis

The University of Warwick, alongside the University of Manchester, are launching a world-first study aimed at determining the length of …

News
Astrazeneca image

AstraZeneca and BTG sepsis drug fails

August 8, 2012
Research and Development, Sales and Marketing AZD977, AstraZeneca, BTG, CytoFab, sepsis

AstraZeneca’s pipeline has suffered another blow with the troubled company halting development of an investigational sepsis drug following poor Phase …

News

Eisai sepsis drug fails in phase III

January 26, 2011
Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis

A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026